| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Foghorn Therapeutics Inc (NASDAQ: FHTX)
FHTX Technical Analysis
3
| As on 13th Jun 2025 FHTX STOCK Price closed @ 4.32 and we RECOMMEND Sell for LONG-TERM with Stoploss of 6.55 & Sell for SHORT-TERM with Stoploss of 5.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FHTXSTOCK Price
| Open | 4.40 | Change | Price | % |
| High | 4.60 | 1 Day | -0.22 | -4.85 |
| Low | 4.31 | 1 Week | 0.12 | 2.86 |
| Close | 4.32 | 1 Month | 0.12 | 2.86 |
| Volume | 67542 | 1 Year | -1.66 | -27.76 |
| 52 Week High 9.99 | 52 Week Low 2.82 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.02 | -33.33% |
| GNLN | 0.01 | -50.00% |
| AMRS | 0.14 | 100.00% |
| NVDA | 141.97 | -2.09% |
| TSLA | 325.31 | 1.94% |
| LMDX | 0.02 | 0.00% |
| NCNA | 0.11 | -26.67% |
| USEG | 2.21 | 55.63% |
| AKTS | 0.04 | 0.00% |
| LCID | 2.10 | -2.78% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FHTX Daily Charts |
FHTX Intraday Charts |
Whats New @ Bazaartrend |
FHTX Free Analysis |
|
|
FHTX Important Levels Intraday
| RESISTANCE | 4.88 |
| RESISTANCE | 4.70 |
| RESISTANCE | 4.59 |
| RESISTANCE | 4.48 |
| SUPPORT | 4.16 |
| SUPPORT | 4.05 |
| SUPPORT | 3.94 |
| SUPPORT | 3.76 |
FHTX Forecast June 2025
| 4th UP Forecast | 13.38 |
| 3rd UP Forecast | 10.47 |
| 2nd UP Forecast | 8.68 |
| 1st UP Forecast | 6.88 |
| 1st DOWN Forecast | 1.76 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -1.83 |
| 4th DOWN Forecast | -4.74 |
FHTX Weekly Forecast
| 4th UP Forecast | 7.08 |
| 3rd UP Forecast | 6.19 |
| 2nd UP Forecast | 5.65 |
| 1st UP Forecast | 5.10 |
| 1st DOWN Forecast | 3.54 |
| 2nd DOWN Forecast | 2.99 |
| 3rd DOWN Forecast | 2.45 |
| 4th DOWN Forecast | 1.56 |
FHTX Forecast2025
| 4th UP Forecast | 18.87 |
| 3rd UP Forecast | 14.2 |
| 2nd UP Forecast | 11.32 |
| 1st UP Forecast | 8.43 |
| 1st DOWN Forecast | 0.21 |
| 2nd DOWN Forecast | -2.68 |
| 3rd DOWN Forecast | -5.56 |
| 4th DOWN Forecast | -10.23 |
Foghorn Therapeutics Inc ( NASDAQ USA Symbol : FHTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FHTX Business Profile
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia; and FHD-609, a small molecule protein degrader of BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. Foghorn Therapeutics Inc. has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel therapeutics based on disruptors of a specified transcription factor target. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts. Address: 500 Technology Square, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service